{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T11:08:03Z","timestamp":1750763283307,"version":"3.37.3"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012483","name":"High Performance Computing Platform of Jiangsu University","doi-asserted-by":"publisher","award":["18JDG028","21JDG061"],"award-info":[{"award-number":["18JDG028","21JDG061"]}],"id":[{"id":"10.13039\/501100012483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202542"],"award-info":[{"award-number":["82202542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-024-01083-w","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:45:49Z","timestamp":1717062349000},"page":"931-943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunosuppressive regulatory cells in cancer immunotherapy: restrain or modulate?"],"prefix":"10.1007","volume":"37","author":[{"given":"Yan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinggang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2100-4100","authenticated-orcid":false,"given":"Manli","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"issue":"10","key":"1083_CR1","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/eji.201546178","volume":"46","author":"M Pinti","year":"2016","unstructured":"Pinti M, Appay V, Campisi J, Frasca D, F\u00fcl\u00f6p T, Sauce D, Larbi A, Weinberger B, Cossarizza A. Aging of the immune system: focus on inflammation and vaccination. Eur J Immunol. 2016;46(10):2286\u2013301.","journal-title":"Eur J Immunol"},{"issue":"1","key":"1083_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chom.2018.12.006","volume":"25","author":"MG Netea","year":"2019","unstructured":"Netea MG, Schlitzer A, Placek K, Joosten LAB, Schultze JL. Innate and adaptive immune memory: an evolutionary continuum in the host\u2019s response to pathogens. Cell Host Microbe. 2019;25(1):13\u201326.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"1083_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00262-018-2170-8","volume":"68","author":"AM Bruger","year":"2019","unstructured":"Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA, et al. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions. Cancer Immunol Immunother CII. 2019;68(4):631\u201344.","journal-title":"Cancer Immunol Immunother CII"},{"issue":"1","key":"1083_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Cell Res. 2017;27(1):109\u201318.","journal-title":"Cell Res"},{"issue":"8","key":"1083_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/15384047.2018.1450116","volume":"19","author":"F Li","year":"2018","unstructured":"Li F, Zhao Y, Wei L, Li S, Liu J. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer. Cancer Biol Ther. 2018;19(8):695\u2013705.","journal-title":"Cancer Biol Ther"},{"key":"1083_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ebiom.2019.08.025","volume":"47","author":"L Fultang","year":"2019","unstructured":"Fultang L, Panetti S, Ng M, Collins P, Graef S, Rizkalla N, Booth S, Lenton R, Noyvert B, Shannon-Lowe C, et al. MDSC targeting with gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers. EBioMedicine. 2019;47:235\u201346.","journal-title":"EBioMedicine"},{"issue":"16","key":"1083_CR7","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1042\/CS20200799","volume":"134","author":"B Pang","year":"2020","unstructured":"Pang B, Zhen Y, Hu C, Ma Z, Lin S, Yi H. Myeloid-derived suppressor cells shift Th17\/Treg ratio and promote systemic lupus erythematosus progression through arginase-1\/miR-322-5p\/TGF-\u03b2 pathway. Clin Sci Lond. 2020;134(16):2209\u201322.","journal-title":"Clin Sci Lond"},{"issue":"1","key":"1083_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","volume":"179","author":"X Chen","year":"2007","unstructured":"Chen X, B\u00e4umel M, M\u00e4nnel DN, Howard OM, Oppenheim JJ. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol. 2007;179(1):154\u201361.","journal-title":"J Immunol"},{"issue":"7","key":"1083_CR9","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00262-021-03081-5","volume":"71","author":"L Gneo","year":"2022","unstructured":"Gneo L, Rizkalla N, Hejmadi R, Mussai F, de Santo C, Middleton G. TGF-beta orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer. Cancer Immunol Immunother CII. 2022;71(7):1583\u201396.","journal-title":"Cancer Immunol Immunother CII"},{"issue":"7","key":"1083_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41388-021-02132-6","volume":"41","author":"RJ King","year":"2022","unstructured":"King RJ, Shukla SK, He C, Vernucci E, Thakur R, Attri KS, Dasgupta A, Chaika NV, Mulder SE, Abrego J, et al. CD73 induces GM-CSF\/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Oncogene. 2022;41(7):971\u201382.","journal-title":"Oncogene"},{"issue":"5","key":"1083_CR11","first-page":"1352","volume":"78","author":"Y Li","year":"2023","unstructured":"Li Y, Yang B, Miao H, Liu L, Wang Z, Jiang C, Yang Y, Qiu S, Li X, Geng Y, et al. Nicotinamide N -methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma. Hepatology. 2023;78(5):1352\u201367.","journal-title":"Hepatology"},{"key":"1083_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.coi.2018.03.009","volume":"51","author":"E Tcyganov","year":"2018","unstructured":"Tcyganov E, Mastio J, Chen E, Gabrilovich DI. Plasticity of myeloid-derived suppressor cells in cancer. Curr Opin Immunol. 2018;51:76\u201382.","journal-title":"Curr Opin Immunol"},{"key":"1083_CR13","doi-asserted-by":"publisher","first-page":"932298","DOI":"10.3389\/fimmu.2022.932298","volume":"13","author":"A Marguier","year":"2022","unstructured":"Marguier A, Laheurte C, Lecoester B, Malfroy M, Boullerot L, Renaudin A, Seffar E, Kumar A, Nardin C, Aubin F, et al. TIE-2 signaling activation by angiopoietin 2 on myeloid-derived suppressor cells promotes melanoma-specific T-cell inhibition. Front Immunol. 2022;13:932298.","journal-title":"Front Immunol"},{"issue":"4","key":"1083_CR14","doi-asserted-by":"publisher","first-page":"e1303585","DOI":"10.1080\/2162402X.2017.1303585","volume":"6","author":"R Turrini","year":"2017","unstructured":"Turrini R, Pabois A, Xenarios I, Coukos G, Delaloye JF, Doucey MA. TIE-2 expressing monocytes in human cancers. Oncoimmunology. 2017;6(4):e1303585.","journal-title":"Oncoimmunology"},{"key":"1083_CR15","doi-asserted-by":"publisher","first-page":"104277","DOI":"10.1016\/j.cellimm.2020.104277","volume":"361","author":"P Innamarato","year":"2021","unstructured":"Innamarato P, Pilon-Thomas S. Reactive myelopoiesis and the onset of myeloid-mediated immune suppression: Implications for adoptive cell therapy. Cell Immunol. 2021;361:104277.","journal-title":"Cell Immunol"},{"issue":"6077","key":"1083_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.1219179","volume":"336","author":"C Schulz","year":"2012","unstructured":"Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Sci New York. 2012;336(6077):86\u201390.","journal-title":"Sci New York"},{"issue":"6610","key":"1083_CR17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1126\/science.abj2674","volume":"377","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yan J, Tao Y, Qian X, Zhang C, Yin L, Gu P, Liu Y, Pan Y, Tang R, et al. Pituitary hormone \u03b1-MSH promotes tumor-induced myelopoiesis and immunosuppression. Science. 2022;377(6610):1085\u201391.","journal-title":"Science"},{"key":"1083_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellimm.2018.07.003","volume":"332","author":"I Bah","year":"2018","unstructured":"Bah I, Kumbhare A, Nguyen L, McCall CE, El Gazzar M. IL-10 induces an immune repressor pathway in sepsis by promoting S100A9 nuclear localization and MDSC development. Cell Immunol. 2018;332:32\u20138.","journal-title":"Cell Immunol"},{"issue":"6\u20137","key":"1083_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","volume":"91","author":"JG Bode","year":"2012","unstructured":"Bode JG, Albrecht U, H\u00e4ussinger D, Heinrich PC, Schaper F. Hepatic acute phase proteins\u2013regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-\u03baB-dependent signaling. Eur J Cell Biol. 2012;91(6\u20137):496\u2013505.","journal-title":"Eur J Cell Biol"},{"issue":"5","key":"1083_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22(5):280\u201397.","journal-title":"Nat Rev Cancer"},{"key":"1083_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuint.2015.10.006","volume":"91","author":"Y Lv","year":"2015","unstructured":"Lv Y, Zhang B, Zhai C, Qiu J, Zhang Y, Yao W, Zhang C. PFKFB3-mediated glycolysis is involved in reactive astrocyte proliferation after oxygen-glucose deprivation\/reperfusion and is regulated by Cdh1. Neurochem Int. 2015;91:26\u201333.","journal-title":"Neurochem Int"},{"issue":"12","key":"1083_CR22","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1158\/0008-5472.CAN-20-3564","volume":"81","author":"R Li","year":"2021","unstructured":"Li R, Salehi-Rad R, Crosson W, Momcilovic M, Lim RJ, Ong SL, Huang ZL, Zhang T, Abascal J, Dumitras C, et al. Inhibition of granulocytic myeloid-derived suppressor cells overcomes resistance to immune checkpoint inhibition in LKB1-deficient non-small cell lung cancer. Cancer Res. 2021;81(12):3295\u2013308.","journal-title":"Cancer Res"},{"issue":"1","key":"1083_CR23","doi-asserted-by":"publisher","first-page":"e12798","DOI":"10.15252\/emmm.202012798","volume":"13","author":"W Lu","year":"2021","unstructured":"Lu W, Yu W, He J, Liu W, Yang J, Lin X, Zhang Y, Wang X, Jiang W, Luo J, et al. Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer. EMBO Mol Med. 2021;13(1):e12798.","journal-title":"EMBO Mol Med"},{"issue":"23","key":"1083_CR24","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1158\/0008-5472.CAN-21-1337","volume":"81","author":"C Liu","year":"2021","unstructured":"Liu C, Qiang J, Deng Q, Xia J, Deng L, Zhou L, Wang D, He X, Liu Y, Zhao B, et al. ALDH1A1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression. Cancer Res. 2021;81(23):5919\u201334.","journal-title":"Cancer Res"},{"issue":"1","key":"1083_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-019-0797-3","volume":"12","author":"M Lv","year":"2019","unstructured":"Lv M, Wang K, Huang XJ. Myeloid-derived suppressor cells in hematological malignancies: friends or foes. J Hematol Oncol. 2019;12(1):105.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"1083_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nm.4086","volume":"22","author":"T Saito","year":"2016","unstructured":"Saito T, Nishikawa H, Wada H, Nagano Y, Sugiyama D, Atarashi K, Maeda Y, Hamaguchi M, Ohkura N, Sato E, et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat Med. 2016;22(6):679\u201384.","journal-title":"Nat Med"},{"issue":"44","key":"1083_CR27","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1073\/pnas.1316796110","volume":"110","author":"D Sugiyama","year":"2013","unstructured":"Sugiyama D, Nishikawa H, Maeda Y, Nishioka M, Tanemura A, Katayama I, Ezoe S, Kanakura Y, Sato E, Fukumori Y, et al. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc Nat Acad Sci USA. 2013;110(44):17945\u201350.","journal-title":"Proc Nat Acad Sci USA"},{"issue":"1","key":"1083_CR28","doi-asserted-by":"publisher","first-page":"e000169","DOI":"10.1136\/jitc-2019-000169","volume":"8","author":"F Bai","year":"2020","unstructured":"Bai F, Zhang P, Fu Y, Chen H, Zhang M, Huang Q, Li D, Li B, Wu K. Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer. J Immunother Cancer. 2020;8(1):e000169.","journal-title":"J Immunother Cancer."},{"issue":"11","key":"1083_CR29","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1158\/2326-6066.CIR-17-0131","volume":"5","author":"EJ Colbeck","year":"2017","unstructured":"Colbeck EJ, Jones E, Hindley JP, Smart K, Schulz R, Browne M, Cutting S, Williams A, Parry L, Godkin A, et al. Treg depletion licenses T cell-driven HEV neogenesis and promotes tumor destruction. Cancer Immunol Res. 2017;5(11):1005\u201315.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"1083_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I. Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124(2):359\u201367.","journal-title":"Br J Cancer"},{"key":"1083_CR31","doi-asserted-by":"publisher","first-page":"215598","DOI":"10.1016\/j.canlet.2022.215598","volume":"532","author":"X Zhou","year":"2022","unstructured":"Zhou X, Fang D, Liu H, Ou X, Zhang C, Zhao Z, Zhao S, Peng J, Cai S, He Y, et al. PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer. Cancer Lett. 2022;532:215598.","journal-title":"Cancer Lett"},{"issue":"11","key":"1083_CR32","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","volume":"8","author":"F Shan","year":"2022","unstructured":"Shan F, Somasundaram A, Bruno TC, Workman CJ, Vignali DAA. Therapeutic targeting of regulatory T cells in cancer. Trends Cancer. 2022;8(11):944\u201361.","journal-title":"Trends Cancer"},{"issue":"1","key":"1083_CR33","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/jcmm.14825","volume":"24","author":"J Tao","year":"2020","unstructured":"Tao J, Han D, Gao S, Zhang W, Yu H, Liu P, Fu R, Li L, Shao Z. CD8(+) T cells exhaustion induced by myeloid-derived suppressor cells in myelodysplastic syndromes patients might be through TIM3\/Gal-9 pathway. J Cell Mol Med. 2020;24(1):1046\u201358.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1083_CR34","doi-asserted-by":"publisher","first-page":"188891","DOI":"10.1016\/j.bbcan.2023.188891","volume":"1878","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ouyang Y, Li Z, Wang X, Ma J. S100A8 and S100A9 in cancer. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188891.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1083_CR35","doi-asserted-by":"publisher","first-page":"616837","DOI":"10.3389\/fimmu.2021.616837","volume":"12","author":"M Bourhis","year":"2021","unstructured":"Bourhis M, Palle J, Galy-Fauroux I, Terme M. Direct and indirect modulation of T cells by VEGF-A counteracted by anti-angiogenic treatment. Front Immunol. 2021;12:616837.","journal-title":"Front Immunol"},{"key":"1083_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aba9600","author":"H Torrey","year":"2020","unstructured":"Torrey H, K\u00fchtreiber WM, Okubo Y, Tran L, Case K, Zheng H, Vanamee E, Faustman DL. A novel TNFR2 agonist antibody expands highly potent regulatory T cells. Sci Signal. 2020. https:\/\/doi.org\/10.1126\/scisignal.aba9600.","journal-title":"Sci Signal"},{"issue":"9","key":"1083_CR37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins F, Sofiya L, Sykiotis GP, Lamine F, Maillard M, Fraga M, Shabafrouz K, Ribi C, Cairoli A, Guex-Crosier Y, et al. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Rev Clin Oncol. 2019;16(9):563\u201380.","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 1","key":"1083_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-018-0384-3","volume":"19","author":"M Lacouture","year":"2018","unstructured":"Lacouture M, Sibaud V. Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails. Am J Clin Dermatol. 2018;19(Suppl 1):31\u20139.","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"1083_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s42255-020-00271-w","volume":"2","author":"S de Kivit","year":"2020","unstructured":"de Kivit S, Mensink M, Hoekstra AT, Berlin I, Derks RJE, Both D, Aslam MA, Amsen D, Berkers CR, Borst J. Stable human regulatory T cells switch to glycolysis following TNF receptor 2 costimulation. Nat Metab. 2020;2(10):1046\u201361.","journal-title":"Nat Metab"},{"issue":"4","key":"1083_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00262-019-02302-2","volume":"68","author":"L Cassetta","year":"2019","unstructured":"Cassetta L, Baekkevold ES, Brandau S, Bujko A, Cassatella MA, Dorhoi A, Krieg C, Lin A, Lore K, Marini O, et al. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates. Cancer Immunol Immunother CII. 2019;68(4):687\u201397.","journal-title":"Cancer Immunol Immunother CII"},{"key":"1083_CR41","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150.","journal-title":"Nat Commun"},{"issue":"1","key":"1083_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, Shu P, Li D, Wang Y. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6(1):362.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"1083_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1182\/blood-2018-10-881722","volume":"133","author":"RM Sterner","year":"2019","unstructured":"Sterner RM, Sakemura R, Cox MJ, Yang N, Khadka RH, Forsman CL, Hansen MJ, Jin F, Ayasoufi K, Hefazi M, et al. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts. Blood. 2019;133(7):697\u2013709.","journal-title":"Blood"},{"issue":"6288","key":"1083_CR44","doi-asserted-by":"publisher","first-page":"aad3018","DOI":"10.1126\/science.aad3018","volume":"352","author":"DF Quail","year":"2016","unstructured":"Quail DF, Bowman RL, Akkari L, Quick ML, Schuhmacher AJ, Huse JT, Holland EC, Sutton JC, Joyce JA. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science. 2016;352(6288):aad3018.","journal-title":"Science"},{"key":"1083_CR45","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.2147\/CMAR.S165226","volume":"10","author":"L Zhang","year":"2018","unstructured":"Zhang L, Tao L, Guo L, Zhan J, Yuan C, Ma Z, Jiang B, Xiu D. G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma. Cancer Manag Res. 2018;10:2767\u201375.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"1083_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.9738\/INTSURG-D-13-00265.1","volume":"99","author":"T Shimakawa","year":"2014","unstructured":"Shimakawa T, Asaka S, Usuda A, Yamaguchi K, Yoshimatsu K, Shiozawa S, Katsube T, Naritaka Y. Granulocyte-colony stimulating factor (G-CSF)-producing esophageal squamous cell carcinoma: a case report. Int Surg. 2014;99(3):280\u20135.","journal-title":"Int Surg"},{"issue":"5","key":"1083_CR47","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/bjc.2013.822","volume":"110","author":"KT Morris","year":"2014","unstructured":"Morris KT, Khan H, Ahmad A, Weston LL, Nofchissey RA, Pinchuk IV, Beswick EJ. G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. Br J Cancer. 2014;110(5):1211\u201320.","journal-title":"Br J Cancer"},{"issue":"6","key":"1083_CR48","first-page":"1361","volume":"13","author":"XG Fu","year":"2020","unstructured":"Fu XG, Deng J, Xu WJ, Chen JY, Sun J, Deng H. Histidine decarboxylase-expressing PMN-MDSC-derived TGF-\u03b21 promotes the epithelial-mesenchymal transition of metastatic lung adenocarcinoma. Int J Clin Exp Pathol. 2020;13(6):1361\u201371.","journal-title":"Int J Clin Exp Pathol"},{"key":"1083_CR49","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.200719","author":"J Lv","year":"2021","unstructured":"Lv J, Zhao Y, Zong H, Ma G, Wei X, Zhao Y. Increased levels of circulating monocytic- and early-stage myeloid-derived suppressor cells (MDSC) in acute myeloid leukemia. Clin Lab. 2021. https:\/\/doi.org\/10.7754\/Clin.Lab.2020.200719.","journal-title":"Clin Lab"},{"key":"1083_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw9159","author":"Y Si","year":"2019","unstructured":"Si Y, Merz SF, Jansen P, Wang B, Bruderek K, Altenhoff P, Mattheis S, Lang S, Gunzer M, Klode J, et al. Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue. Sci Immunol. 2019. https:\/\/doi.org\/10.1126\/sciimmunol.aaw9159.","journal-title":"Sci Immunol"},{"issue":"1","key":"1083_CR51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4049\/jimmunol.1701069","volume":"201","author":"Y Wang","year":"2018","unstructured":"Wang Y, Schafer CC, Hough KP, Tousif S, Duncan SR, Kearney JF, Ponnazhagan S, Hsu HC, Deshane JS. Myeloid-derived suppressor cells impair B cell responses in lung cancer through IL-7 and STAT5. J Immunol. 2018;201(1):278\u201395.","journal-title":"J Immunol"},{"issue":"3","key":"1083_CR52","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.23054","volume":"50","author":"B Hoechst","year":"2009","unstructured":"Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology. 2009;50(3):799\u2013807.","journal-title":"Hepatology"},{"issue":"5","key":"1083_CR53","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.apsb.2019.09.006","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Pan X, Zhang W, Guo H, Cheng S, He Q, Yang B, Ding L. Epigenetic strategies synergize with PD-L1\/PD-1 targeted cancer immunotherapies to enhance antitumor responses. Acta Pharmaceutica Sinica B. 2020;10(5):723\u201333.","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"20","key":"1083_CR54","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1158\/0008-5472.CAN-14-1848","volume":"75","author":"S Peyvandi","year":"2015","unstructured":"Peyvandi S, Buart S, Samah B, V\u00e9tizou M, Zhang Y, Durrieu L, Polrot M, Chouaib S, Benihoud K, Louache F, et al. Fas ligand deficiency impairs tumor immunity by promoting an accumulation of monocytic myeloid-derived suppressor cells. Cancer Res. 2015;75(20):4292\u2013301.","journal-title":"Cancer Res"},{"issue":"6","key":"1083_CR55","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.4049\/jimmunol.0801548","volume":"182","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Liu Q, Zhang M, Yu Y, Liu X, Cao X. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2. J Immunol. 2009;182(6):3801\u20138.","journal-title":"J Immunol"},{"issue":"5","key":"1083_CR56","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"MZ Noman","year":"2014","unstructured":"Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, Bronte V, Chouaib S. PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211(5):781\u201390.","journal-title":"J Exp Med"},{"key":"1083_CR57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2017762118","author":"W Zheng","year":"2021","unstructured":"Zheng W, Song H, Luo Z, Wu H, Chen L, Wang Y, Cui H, Zhang Y, Wang B, Li W, et al. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR\/ERK pathway. Proc Nat Acad Sci USA. 2021. https:\/\/doi.org\/10.1073\/pnas.2017762118.","journal-title":"Proc Nat Acad Sci USA"},{"issue":"7","key":"1083_CR58","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14737159.2018.1470929","volume":"18","author":"A Romano","year":"2018","unstructured":"Romano A, Parrinello NL, La Cava P, Tibullo D, Giallongo C, Camiolo G, Puglisi F, Parisi M, Pirosa MC, Martino E, et al. PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy. Expert Rev Mol Diagn. 2018;18(7):675\u201383.","journal-title":"Expert Rev Mol Diagn"},{"key":"1083_CR59","first-page":"3","volume":"410","author":"Y Togashi","year":"2017","unstructured":"Togashi Y, Nishikawa H. Regulatory T cells: molecular and cellular basis for immunoregulation. Curr Top Microbiol Immunol. 2017;410:3\u201327.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"1083_CR60","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490\u2013500.","journal-title":"Nat Rev Immunol"},{"key":"1083_CR61","doi-asserted-by":"publisher","first-page":"10411","DOI":"10.2147\/CMAR.S265828","volume":"12","author":"G Zeng","year":"2020","unstructured":"Zeng G, Jin L, Ying Q, Chen H, Thembinkosi MC, Yang C, Zhao J, Ji H, Lin S, Peng R, et al. Regulatory T cells in cancer immunotherapy: basic research outcomes and clinical directions. Cancer Manag Res. 2020;12:10411\u201321.","journal-title":"Cancer Manag Res"},{"issue":"6","key":"1083_CR62","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16(6):356\u201371.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"1083_CR63","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1681\/ASN.2004100837","volume":"16","author":"D Wolf","year":"2005","unstructured":"Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H, Mayer G, Gunsilius E, Rosenkranz AR. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol JASN. 2005;16(5):1360\u201370.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"8","key":"1083_CR64","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1182\/blood-2007-06-094656","volume":"110","author":"DQ Tran","year":"2007","unstructured":"Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood. 2007;110(8):2983\u201390.","journal-title":"Blood"},{"issue":"1","key":"1083_CR65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s13402-022-00742-0","volume":"46","author":"T He","year":"2023","unstructured":"He T, Chen Y, Yang D, Islam MS, Chou CK, Liu J, Faustman DL, Oppenheim JJ, Chen X. TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4(+)Foxp3(+) regulatory T cells. Cell Oncol Dordr. 2023;46(1):167\u201377.","journal-title":"Cell Oncol Dordr"},{"issue":"11","key":"1083_CR66","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00262-015-1751-z","volume":"64","author":"F Yan","year":"2015","unstructured":"Yan F, Du R, Wei F, Zhao H, Yu J, Wang C, Zhan Z, Ding T, Ren X, Chen X, et al. Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients. Cancer immunol Immunother CII. 2015;64(11):1475\u201385.","journal-title":"Cancer immunol Immunother CII"},{"key":"1083_CR67","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3389\/fimmu.2018.01556","volume":"9","author":"T He","year":"2018","unstructured":"He T, Liu S, Chen S, Ye J, Wu X, Bian Z, Chen X. The p38 MAPK inhibitor SB203580 abrogates tumor necrosis factor-induced proliferative expansion of mouse CD4(+)Foxp3(+) regulatory T cells. Front Immunol. 2018;9:1556.","journal-title":"Front Immunol"},{"issue":"24","key":"1083_CR68","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.21037\/atm-20-7181","volume":"8","author":"LL Ye","year":"2020","unstructured":"Ye LL, Peng WB, Niu YR, Xiang X, Wei XS, Wang ZH, Wang X, Zhang SY, Chen X, Zhou Q. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis. Ann Transl Med. 2020;8(24):1647.","journal-title":"Ann Transl Med"},{"key":"1083_CR69","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3389\/fimmu.2017.01482","volume":"8","author":"NC Kampan","year":"2017","unstructured":"Kampan NC, Madondo MT, McNally OM, Stephens AN, Quinn MA, Plebanski M. Interleukin 6 present in inflammatory ascites from advanced epithelial ovarian cancer patients promotes tumor necrosis factor receptor 2-expressing regulatory T cells. Front Immunol. 2017;8:1482.","journal-title":"Front Immunol"},{"issue":"1","key":"1083_CR70","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.clim.2013.07.003","volume":"149","author":"C Govindaraj","year":"2013","unstructured":"Govindaraj C, Scalzo-Inguanti K, Madondo M, Hallo J, Flanagan K, Quinn M, Plebanski M. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment. Clin Immunol. 2013;149(1):97\u2013110.","journal-title":"Clin Immunol"},{"key":"1083_CR71","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3389\/fimmu.2018.01274","volume":"9","author":"M Wang","year":"2018","unstructured":"Wang M, Zhang C, Tian T, Zhang T, Wang R, Han F, Zhong C, Hua M, Ma D. Increased regulatory T cells in peripheral blood of acute myeloid leukemia patients rely on tumor necrosis factor (TNF)-alpha-TNF receptor-2 pathway. Front Immunol. 2018;9:1274.","journal-title":"Front Immunol"},{"issue":"8","key":"1083_CR72","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/ajh.23746","volume":"89","author":"C Govindaraj","year":"2014","unstructured":"Govindaraj C, Madondo M, Kong YY, Tan P, Wei A, Plebanski M. Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients. Am J Hematol. 2014;89(8):795\u2013802.","journal-title":"Am J Hematol"},{"issue":"7","key":"1083_CR73","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00262-020-02549-0","volume":"69","author":"M Dadiani","year":"2020","unstructured":"Dadiani M, Necula D, Kahana-Edwin S, Oren N, Baram T, Marin I, Morzaev-Sulzbach D, Pavlovski A, Balint-Lahat N, Anafi L, et al. TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients. Cancer Immunol Immunother CII. 2020;69(7):1315\u201326.","journal-title":"Cancer Immunol Immunother CII"},{"issue":"8","key":"1083_CR74","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ijc.33873","volume":"150","author":"Y Qu","year":"2022","unstructured":"Qu Y, Wang X, Bai S, Niu L, Zhao G, Yao Y, Li B, Li H. The effects of TNF-alpha\/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer. Int J Cancer. 2022;150(8):1373\u201391.","journal-title":"Int J Cancer"},{"issue":"8","key":"1083_CR75","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/1744666X.2019.1629904","volume":"15","author":"C Kotch","year":"2019","unstructured":"Kotch C, Barrett D, Teachey DT. Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome. Expert Rev Clin Immunol. 2019;15(8):813\u201322.","journal-title":"Expert Rev Clin Immunol"},{"issue":"5609","key":"1083_CR76","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Sci New York. 2003;299(5609):1057\u201361.","journal-title":"Sci New York"},{"issue":"9","key":"1083_CR77","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.0915174107","volume":"107","author":"MA Curran","year":"2010","unstructured":"Curran MA, Montalvo W, Yagita H, Allison JP. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Nat Acad Sci USA. 2010;107(9):4275\u201380.","journal-title":"Proc Nat Acad Sci USA"},{"key":"1083_CR78","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003892","author":"A Revenko","year":"2022","unstructured":"Revenko A, Carnevalli LS, Sinclair C, Johnson B, Peter A, Taylor M, Hettrick L, Chapman M, Klein S, Solanki A, et al. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2021-003892.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"1083_CR79","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","volume":"190","author":"X Chen","year":"2013","unstructured":"Chen X, Wu X, Zhou Q, Howard OM, Netea MG, Oppenheim JJ. TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T cell phenotype in the inflammatory environment. J Immunol. 2013;190(3):1076\u201384.","journal-title":"J Immunol"},{"key":"1083_CR80","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan0790","author":"Y Nie","year":"2018","unstructured":"Nie Y, He J, Shirota H, Trivett AL, Yang D, Klinman DM, Oppenheim JJ, Chen X. Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer. Sci Signal. 2018. https:\/\/doi.org\/10.1126\/scisignal.aan0790.","journal-title":"Sci Signal"},{"issue":"2","key":"1083_CR81","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s43032-020-00299-z","volume":"28","author":"L Zhu","year":"2021","unstructured":"Zhu L, Liu M, Zhang S, Ou Y, Chen Y, Wei J, Su F, Chen H, Zhang J. Foxp3 TSDR hypermethylation is correlated with decreased Tregs in patients with unexplained recurrent spontaneous abortion. Reprod Sci. 2021;28(2):470\u20138.","journal-title":"Reprod Sci"},{"key":"1083_CR82","doi-asserted-by":"publisher","first-page":"682262","DOI":"10.3389\/fimmu.2021.682262","volume":"12","author":"S Liang","year":"2021","unstructured":"Liang S, Yang J, Lin Y, Li T, Zhao W, Zhao J, Dong C. Immune myocarditis overlapping with myasthenia gravis due to anti-PD-1 treatment for a chordoma patient: a case report and literature review. Front Immunol. 2021;12:682262.","journal-title":"Front Immunol"},{"issue":"5","key":"1083_CR83","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1001\/jamaoncol.2021.0051","volume":"7","author":"JR Patrinely Jr","year":"2021","unstructured":"Patrinely JR Jr, Johnson R, Lawless AR, Bhave P, Sawyers A, Dimitrova M, Yeoh HL, Palmeri M, Ye F, Fan R, et al. Chronic immune-related adverse events following adjuvant anti-PD-1 therapy for high-risk resected melanoma. JAMA Oncol. 2021;7(5):744\u20138.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1083_CR84","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. New England J Med. 2018;378(2):158\u201368.","journal-title":"New England J Med"},{"issue":"13","key":"1083_CR85","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.1158\/0008-5472.CAN-05-3755","volume":"66","author":"R Yang","year":"2006","unstructured":"Yang R, Cai Z, Zhang Y, Yutzy WHt, Roby KF, Roden RB. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res. 2006;66(13):6807\u201315.","journal-title":"Cancer Res"},{"issue":"2","key":"1083_CR86","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","volume":"66","author":"B Huang","year":"2006","unstructured":"Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J, Divino CM, Chen SH. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006;66(2):1123\u201331.","journal-title":"Cancer Res"},{"key":"1083_CR87","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004032","author":"C Ieran\u00f2","year":"2022","unstructured":"Ieran\u00f2 C, Righelli D, D\u2019Alterio C, Napolitano M, Portella L, Rea G, Auletta F, Santagata S, Trotta AM, Guardascione G, et al. In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2021-004032.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"1083_CR88","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41571-021-00564-3","volume":"19","author":"FG Dall\u2019Olio","year":"2022","unstructured":"Dall\u2019Olio FG, Marabelle A, Caramella C, Garcia C, Aldea M, Chaput N, Robert C, Besse B. Tumour burden and efficacy of immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2022;19(2):75\u201390.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1083_CR89","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/s41467-017-00784-1","volume":"8","author":"J Zhu","year":"2017","unstructured":"Zhu J, Powis de Tenbossche CG, Can\u00e9 S, Colau D, van Baren N, Lurquin C, Schmitt-Verhulst AM, Liljestr\u00f6m P, Uyttenhove C, Van den Eynde BJ. Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes. Nat Commun. 2017;8(1):1404.","journal-title":"Nat Commun"},{"issue":"2","key":"1083_CR90","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/08923973.2014.897727","volume":"36","author":"P Chakraborty","year":"2014","unstructured":"Chakraborty P, Das S, Banerjee K, Sinha A, Roy S, Chatterjee M, Choudhuri SK. A copper chelate selectively triggers apoptosis in myeloid-derived suppressor cells in a drug-resistant tumor model and enhances antitumor immune response. Immunopharmacol Immunotoxicol. 2014;36(2):165\u201375.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"1083_CR91","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","volume":"267","author":"G Soria","year":"2008","unstructured":"Soria G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 2008;267(2):271\u201385.","journal-title":"Cancer Lett"},{"issue":"6","key":"1083_CR92","first-page":"796","volume":"19","author":"JP Antonios","year":"2017","unstructured":"Antonios JP, Soto H, Everson RG, Moughon D, Orpilla JR, Shin NP, Sedighim S, Treger J, Odesa S, Tucker A, et al. Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1\/PD-L1 mechanism in glioblastoma. Neuro Oncol. 2017;19(6):796\u2013807.","journal-title":"Neuro Oncol"},{"issue":"3","key":"1083_CR93","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/2326-6066.CIR-13-0016","volume":"1","author":"Y Pico de Coana","year":"2023","unstructured":"Pico de Coana Y, Poschke I, Gentilcore G, Mao Y, Nystrom M, Hansson J, Masucci GV, Kiessling R. Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production. Cancer Immunol Res. 2023;1(3):158\u201362.","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"1083_CR94","doi-asserted-by":"publisher","first-page":"e1469594","DOI":"10.1080\/2162402X.2018.1469594","volume":"7","author":"L Wang","year":"2018","unstructured":"Wang L, Jia B, Claxton DF, Ehmann WC, Rybka WB, Mineishi S, Naik S, Khawaja MR, Sivik J, Han J, et al. VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML. Oncoimmunology. 2018;7(9):e1469594.","journal-title":"Oncoimmunology"},{"issue":"7","key":"1083_CR95","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1158\/0008-5472.CAN-13-1506","volume":"74","author":"I Le Mercier","year":"2014","unstructured":"Le Mercier I, Chen W, Lines JL, Day M, Li J, Sergent P, Noelle RJ, Wang L. VISTA regulates the development of protective antitumor immunity. Cancer Res. 2014;74(7):1933\u201344.","journal-title":"Cancer Res"},{"issue":"4","key":"1083_CR96","doi-asserted-by":"publisher","first-page":"e1564505","DOI":"10.1080\/2162402X.2018.1564505","volume":"8","author":"E Limagne","year":"2019","unstructured":"Limagne E, Richard C, Thibaudin M, Fumet JD, Truntzer C, Lagrange A, Favier L, Coudert B, Ghiringhelli F. Tim-3\/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients. Oncoimmunology. 2019;8(4):e1564505.","journal-title":"Oncoimmunology"},{"issue":"7","key":"1083_CR97","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41389-020-00248-0","volume":"9","author":"CX Zhang","year":"2020","unstructured":"Zhang CX, Huang DJ, Baloche V, Zhang L, Xu JX, Li BW, Zhao XR, He J, Mai HQ, Chen QY, et al. Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation. Oncogenesis. 2020;9(7):65.","journal-title":"Oncogenesis"},{"issue":"6","key":"1083_CR98","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","volume":"26","author":"RJ Johnston","year":"2014","unstructured":"Johnston RJ, Comps-Agrar L, Hackney J, Yu X, Huseni M, Yang Y, Park S, Javinal V, Chiu H, Irving B, et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell. 2014;26(6):923\u201337.","journal-title":"Cancer Cell"},{"issue":"10","key":"1083_CR99","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1158\/2326-6066.CIR-18-0725","volume":"7","author":"L Wu","year":"2019","unstructured":"Wu L, Mao L, Liu JF, Chen L, Yu GT, Yang LL, Wu H, Bu LL, Kulkarni AB, Zhang WF, et al. Blockade of TIGIT\/CD155 signaling reverses T-cell exhaustion and enhances antitumor capability in head and neck squamous cell carcinoma. Cancer Immunol Res. 2019;7(10):1700\u201313.","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"1083_CR100","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41590-020-0666-9","volume":"21","author":"T Baumann","year":"2020","unstructured":"Baumann T, Dunkel A, Schmid C, Schmitt S, Hiltensperger M, Lohr K, Laketa V, Donakonda S, Ahting U, Lorenz-Depiereux B, et al. Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal. Nat Immunol. 2020;21(5):555\u201366.","journal-title":"Nat Immunol"},{"issue":"11","key":"1083_CR101","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.4049\/jimmunol.1500959","volume":"195","author":"C Cimen Bozkus","year":"2015","unstructured":"Cimen Bozkus C, Elzey BD, Crist SA, Ellies LG, Ratliff TL. Expression of cationic amino acid transporter 2 is required for myeloid-derived suppressor cell-mediated control of T cell immunity. J Immunol. 2015;195(11):5237\u201350.","journal-title":"J Immunol"},{"issue":"1","key":"1083_CR102","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 2010;70(1):68\u201377.","journal-title":"Cancer Res"},{"issue":"11","key":"1083_CR103","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.4049\/jimmunol.1101225","volume":"187","author":"S Ryzhov","year":"2011","unstructured":"Ryzhov S, Novitskiy SV, Goldstein AE, Biktasova A, Blackburn MR, Biaggioni I, Dikov MM, Feoktistov I. Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells. J Immunol. 2011;187(11):6120\u20139.","journal-title":"J Immunol"},{"issue":"12","key":"1083_CR104","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan D, Young A, Teng MWL, Smyth MJ. Targeting immunosuppressive adenosine in cancer. Nat Rev Cancer. 2017;17(12):709\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1083_CR105","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00262-014-1553-8","volume":"63","author":"V Umansky","year":"2014","unstructured":"Umansky V, Shevchenko I, Bazhin AV, Utikal J. Extracellular adenosine metabolism in immune cells in melanoma. Cancer Immunol Immunother CII. 2014;63(10):1073\u201380.","journal-title":"Cancer Immunol Immunother CII"},{"issue":"2","key":"1083_CR106","doi-asserted-by":"publisher","first-page":"937","DOI":"10.4049\/jimmunol.0804253","volume":"183","author":"EM Hanson","year":"2009","unstructured":"Hanson EM, Clements VK, Sinha P, Ilkovitch D, Ostrand-Rosenberg S. Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J Immunol. 2009;183(2):937\u201344.","journal-title":"J Immunol"},{"issue":"11","key":"1083_CR107","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1002\/eji.201343349","volume":"43","author":"E Schouppe","year":"2013","unstructured":"Schouppe E, Mommer C, Movahedi K, Laoui D, Morias Y, Gysemans C, Luyckx A, De Baetselier P, Van Ginderachter JA. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events. Eur J Immunol. 2013;43(11):2930\u201342.","journal-title":"Eur J Immunol"},{"issue":"11","key":"1083_CR108","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1038\/jid.2012.190","volume":"132","author":"AE Gehad","year":"2012","unstructured":"Gehad AE, Lichtman MK, Schmults CD, Teague JE, Calarese AW, Jiang Y, Watanabe R, Clark RA. Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas. J Invest Dermatol. 2012;132(11):2642\u201351.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1083_CR109","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccell.2021.11.002","volume":"40","author":"H Li","year":"2022","unstructured":"Li H, Xiao Y, Li Q, Yao J, Yuan X, Zhang Y, Yin X, Saito Y, Fan H, Li P, et al. The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1. Cancer Cell. 2022;40(1):36-52.e39.","journal-title":"Cancer Cell"},{"issue":"1","key":"1083_CR110","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41467-021-20893-2","volume":"12","author":"A Rodriguez-Garcia","year":"2021","unstructured":"Rodriguez-Garcia A, Lynn RC, Poussin M, Eiva MA, Shaw LC, O\u2019Connor RS, Minutolo NG, Casado-Medrano V, Lopez G, Matsuyama T, et al. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy. Nat Commun. 2021;12(1):877.","journal-title":"Nat Commun"},{"issue":"10","key":"1083_CR111","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1038\/leu.2017.21","volume":"31","author":"EA Eksioglu","year":"2017","unstructured":"Eksioglu EA, Chen X, Heider KH, Rueter B, McGraw KL, Basiorka AA, Wei M, Burnette A, Cheng P, Lancet J, et al. Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858. Leukemia. 2017;31(10):2172\u201380.","journal-title":"Leukemia"},{"issue":"1","key":"1083_CR112","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","volume":"20","author":"CL Flugel","year":"2023","unstructured":"Flugel CL, Majzner RG, Krenciute G, Dotti G, Riddell SR, Wagner DL, Abou-El-Enein M. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours. Nat Rev Clin Oncol. 2023;20(1):49\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1083_CR113","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1158\/1078-0432.CCR-13-1016","volume":"20","author":"SK Perna","year":"2014","unstructured":"Perna SK, Pagliara D, Mahendravada A, Liu H, Brenner MK, Savoldo B, Dotti G. Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibition. Clin Cancer Res Off J Am Assoc Cancer Res. 2014;20(1):131\u20139.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"11","key":"1083_CR114","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1158\/0008-5472.CAN-17-3102","volume":"78","author":"S Hibino","year":"2018","unstructured":"Hibino S, Chikuma S, Kondo T, Ito M, Nakatsukasa H, Omata-Mise S, Yoshimura A. Inhibition of Nr4a receptors enhances antitumor immunity by breaking Treg-mediated immune tolerance. Cancer Res. 2018;78(11):3027\u201340.","journal-title":"Cancer Res"},{"issue":"7749","key":"1083_CR115","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","volume":"567","author":"J Chen","year":"2019","unstructured":"Chen J, L\u00f3pez-Moyado IF, Seo H, Lio CJ, Hempleman LJ, Sekiya T, Yoshimura A, Scott-Browne JP, Rao A. NR4A transcription factors limit CAR T cell function in solid tumours. Nature. 2019;567(7749):530\u20134.","journal-title":"Nature"},{"key":"1083_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112767","author":"Y Hao","year":"2019","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-\u03b2-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20112767.","journal-title":"Int J Mol Sci"},{"key":"1083_CR117","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2022.2138430","author":"S Borzouei","year":"2022","unstructured":"Borzouei S, Gholamian-Hamadan M, Behzad M. Impact of interleukin-32\u03b1 on T helper cell-related cytokines, transcription factors, and proliferation in patients with type 2 diabetes mellitus. Immunopharmacol Immunotoxicol. 2022. https:\/\/doi.org\/10.1080\/08923973.2022.2138430.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"6","key":"1083_CR118","first-page":"1361","volume":"13","author":"XG Fu","year":"2020","unstructured":"Fu XG, Deng J, Xu WJ, Chen JY, Sun J, Deng H. Histidine decarboxylase-expressing PMN-MDSC-derived TGF-beta1 promotes the epithelial-mesenchymal transition of metastatic lung adenocarcinoma. Int J Clin Exp Pathol. 2020;13(6):1361\u201371.","journal-title":"Int J Clin Exp Pathol"},{"key":"1083_CR119","doi-asserted-by":"publisher","first-page":"114541","DOI":"10.1016\/j.biopha.2023.114541","volume":"161","author":"J Mo","year":"2023","unstructured":"Mo J, Hu J, Cheng X. The role of high mobility group box 1 in neuroinflammatory related diseases. Biomed Pharmacother. 2023;161:114541.","journal-title":"Biomed Pharmacother"},{"issue":"23","key":"1083_CR120","doi-asserted-by":"publisher","first-page":"13703","DOI":"10.1111\/jcmm.15928","volume":"24","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zheng G, Li G, Wang M, Ma Z, Li H, Wang XY, Yi H. Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor beta and S100A8\/9 up-regulation. J Cell Mol Med. 2020;24(23):13703\u201314.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"1083_CR121","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41423-022-00859-0","volume":"19","author":"Y Hou","year":"2022","unstructured":"Hou Y, Xie J, Wang S, Li D, Wang L, Wang H, Ni X, Leng S, Li G, Hou M, et al. Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia. Cell Mol Immunol. 2022;19(7):764\u201376.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1083_CR122","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.annonc.2020.10.478","volume":"32","author":"ML Schubert","year":"2021","unstructured":"Schubert ML, Schmitt M, Wang L, Ramos CA, Jordan K, M\u00fcller-Tidow C, Dreger P. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy. Annals Oncol Off J Eur Soc Med Oncol. 2021;32(1):34\u201348.","journal-title":"Annals Oncol Off J Eur Soc Med Oncol"},{"issue":"36","key":"1083_CR123","doi-asserted-by":"publisher","first-page":"22351","DOI":"10.1073\/pnas.2010229117","volume":"117","author":"S Kang","year":"2020","unstructured":"Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, Matsumoto H, Matsuura H, Matsubara T, Shimizu K, et al. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc Nat Acad Sci USA. 2020;117(36):22351\u20136.","journal-title":"Proc Nat Acad Sci USA"},{"issue":"6","key":"1083_CR124","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/14712598.2020.1729735","volume":"20","author":"CK Chou","year":"2020","unstructured":"Chou CK, Turtle CJ. Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy. Expert Opin Biol Ther. 2020;20(6):653\u201364.","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"1083_CR125","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1111\/ajt.16459","volume":"21","author":"S Chandran","year":"2021","unstructured":"Chandran S, Leung J, Hu C, Laszik ZG, Tang Q, Vincenti FG. Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: a randomized controlled trial. Am J Transplant. 2021;21(7):2543\u201354.","journal-title":"Am J Transplant"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01083-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-024-01083-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01083-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T08:06:25Z","timestamp":1719129985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-024-01083-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":125,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1007\/s13577-024-01083-w","relation":{},"ISSN":["1749-0774"],"issn-type":[{"type":"electronic","value":"1749-0774"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}